Design and Analysis Of Trials For A New Tuberculin Standard

K. Frankena, L. Jacobs, A. Duignan, M. Good, M.C.M. de Jong

Research output: Contribution to conferenceAbstractAcademic

Abstract

Introduction
Potencies of tuberculin batches need to be assessed relative to the Bovine International Standard (BIS, potency defined as 32,500 IU/ml), produced in the 1970’s and recognised as the international standard in 1986 by the WHO. Currently both BIS stocks and quality are diminishing. Therefore, a new bovine standard is required which should be of comparable potency to BIS while its estimated potency must be highly precise.
Materials and Methods
A trial was designed using one concentration (100μl of 1mg PPD/ml) of BIS and of a ‘working standard’ (WS) which each was applied 4 times to the same animal. The number of bovines to be included in the trial was simulated using varying estimates of between- and within-bovine variation in skin response. The
trial was conducted with naturally infected steers, showing a positive skin response to SICTT and a positive result to Gamma Interferon assay, selected from herds in which infection was confirmed. Results were analysed using GLMM with standard (BIS, WS) as fixed effect and animal as random effect.
Results
Sample size was set to 30 animals assuming a between-bovine variation of 3.0mm and a within-bovine variation of 2.0mm. Then the 95% CI of the potency estimate is ± 3000IU. In the trial itself, the between and within-bovine variations were 2.4 and 1.3 respectively, resulting in a potency estimate of 34,700 ±
1,400IU/ml for WS in bovines.
Conclusion
Potency estimate of WS and its 95%CI indicate that WS is a good candidate to replace BIS.
Original languageEnglish
Pages61
Publication statusPublished - Jun 2014
Event6th International M. bovis conference - Wales, Cardiff, United Kingdom
Duration: 16 Jun 201419 Jun 2014

Conference

Conference6th International M. bovis conference
CountryUnited Kingdom
CityCardiff
Period16/06/1419/06/14

Fingerprint

tuberculin
cattle
skin (animal)
animals
interferon-gamma
herds
assays

Cite this

Frankena, K., Jacobs, L., Duignan, A., Good, M., & de Jong, M. C. M. (2014). Design and Analysis Of Trials For A New Tuberculin Standard. 61. Abstract from 6th International M. bovis conference, Cardiff, United Kingdom.
Frankena, K. ; Jacobs, L. ; Duignan, A. ; Good, M. ; de Jong, M.C.M. / Design and Analysis Of Trials For A New Tuberculin Standard. Abstract from 6th International M. bovis conference, Cardiff, United Kingdom.
@conference{7cc5db4b6155429f82636d88f24d3f32,
title = "Design and Analysis Of Trials For A New Tuberculin Standard",
abstract = "IntroductionPotencies of tuberculin batches need to be assessed relative to the Bovine International Standard (BIS, potency defined as 32,500 IU/ml), produced in the 1970’s and recognised as the international standard in 1986 by the WHO. Currently both BIS stocks and quality are diminishing. Therefore, a new bovine standard is required which should be of comparable potency to BIS while its estimated potency must be highly precise.Materials and MethodsA trial was designed using one concentration (100μl of 1mg PPD/ml) of BIS and of a ‘working standard’ (WS) which each was applied 4 times to the same animal. The number of bovines to be included in the trial was simulated using varying estimates of between- and within-bovine variation in skin response. Thetrial was conducted with naturally infected steers, showing a positive skin response to SICTT and a positive result to Gamma Interferon assay, selected from herds in which infection was confirmed. Results were analysed using GLMM with standard (BIS, WS) as fixed effect and animal as random effect.ResultsSample size was set to 30 animals assuming a between-bovine variation of 3.0mm and a within-bovine variation of 2.0mm. Then the 95{\%} CI of the potency estimate is ± 3000IU. In the trial itself, the between and within-bovine variations were 2.4 and 1.3 respectively, resulting in a potency estimate of 34,700 ±1,400IU/ml for WS in bovines. ConclusionPotency estimate of WS and its 95{\%}CI indicate that WS is a good candidate to replace BIS.",
author = "K. Frankena and L. Jacobs and A. Duignan and M. Good and {de Jong}, M.C.M.",
year = "2014",
month = "6",
language = "English",
pages = "61",
note = "6th International M. bovis conference ; Conference date: 16-06-2014 Through 19-06-2014",

}

Frankena, K, Jacobs, L, Duignan, A, Good, M & de Jong, MCM 2014, 'Design and Analysis Of Trials For A New Tuberculin Standard' 6th International M. bovis conference, Cardiff, United Kingdom, 16/06/14 - 19/06/14, pp. 61.

Design and Analysis Of Trials For A New Tuberculin Standard. / Frankena, K.; Jacobs, L.; Duignan, A.; Good, M.; de Jong, M.C.M.

2014. 61 Abstract from 6th International M. bovis conference, Cardiff, United Kingdom.

Research output: Contribution to conferenceAbstractAcademic

TY - CONF

T1 - Design and Analysis Of Trials For A New Tuberculin Standard

AU - Frankena, K.

AU - Jacobs, L.

AU - Duignan, A.

AU - Good, M.

AU - de Jong, M.C.M.

PY - 2014/6

Y1 - 2014/6

N2 - IntroductionPotencies of tuberculin batches need to be assessed relative to the Bovine International Standard (BIS, potency defined as 32,500 IU/ml), produced in the 1970’s and recognised as the international standard in 1986 by the WHO. Currently both BIS stocks and quality are diminishing. Therefore, a new bovine standard is required which should be of comparable potency to BIS while its estimated potency must be highly precise.Materials and MethodsA trial was designed using one concentration (100μl of 1mg PPD/ml) of BIS and of a ‘working standard’ (WS) which each was applied 4 times to the same animal. The number of bovines to be included in the trial was simulated using varying estimates of between- and within-bovine variation in skin response. Thetrial was conducted with naturally infected steers, showing a positive skin response to SICTT and a positive result to Gamma Interferon assay, selected from herds in which infection was confirmed. Results were analysed using GLMM with standard (BIS, WS) as fixed effect and animal as random effect.ResultsSample size was set to 30 animals assuming a between-bovine variation of 3.0mm and a within-bovine variation of 2.0mm. Then the 95% CI of the potency estimate is ± 3000IU. In the trial itself, the between and within-bovine variations were 2.4 and 1.3 respectively, resulting in a potency estimate of 34,700 ±1,400IU/ml for WS in bovines. ConclusionPotency estimate of WS and its 95%CI indicate that WS is a good candidate to replace BIS.

AB - IntroductionPotencies of tuberculin batches need to be assessed relative to the Bovine International Standard (BIS, potency defined as 32,500 IU/ml), produced in the 1970’s and recognised as the international standard in 1986 by the WHO. Currently both BIS stocks and quality are diminishing. Therefore, a new bovine standard is required which should be of comparable potency to BIS while its estimated potency must be highly precise.Materials and MethodsA trial was designed using one concentration (100μl of 1mg PPD/ml) of BIS and of a ‘working standard’ (WS) which each was applied 4 times to the same animal. The number of bovines to be included in the trial was simulated using varying estimates of between- and within-bovine variation in skin response. Thetrial was conducted with naturally infected steers, showing a positive skin response to SICTT and a positive result to Gamma Interferon assay, selected from herds in which infection was confirmed. Results were analysed using GLMM with standard (BIS, WS) as fixed effect and animal as random effect.ResultsSample size was set to 30 animals assuming a between-bovine variation of 3.0mm and a within-bovine variation of 2.0mm. Then the 95% CI of the potency estimate is ± 3000IU. In the trial itself, the between and within-bovine variations were 2.4 and 1.3 respectively, resulting in a potency estimate of 34,700 ±1,400IU/ml for WS in bovines. ConclusionPotency estimate of WS and its 95%CI indicate that WS is a good candidate to replace BIS.

M3 - Abstract

SP - 61

ER -

Frankena K, Jacobs L, Duignan A, Good M, de Jong MCM. Design and Analysis Of Trials For A New Tuberculin Standard. 2014. Abstract from 6th International M. bovis conference, Cardiff, United Kingdom.